On the occasion of World Diabetes Day, which was celebrated worldwide a few weeks ago, the Israeli company Petaline Therapeutics announced that it has obtained a global patent on the development and maintenance of insulin in the body, through the development of a miniaturized pancreas capable of sustainably maintaining the insulin levels needed by patients with diabetes. If effective, this can cure both types of diabetes.
In an announcement posted on the “Israel Speaks Arabic” page on Facebook, the company says that after the new member is transplanted, it takes 3 to 5 days before insulin production can begin.
Diabetes is a chronic and fatal disease. Experts call him a “silent killer” because many patients are unaware of their illness. The number of people with diabetes worldwide exceeded 422 million in 2014, according to the United Nations, which confirms in a report that the rate of spread of diabetes has increased dramatically since 1980, from 4.7% to 8.5% among adults. In 2017, 600 million people were infected, including 83 million in the Middle East, according to the International Diabetes Federation.
According to the World Health Organization, diabetes is expected to be the leading cause of death in 2030.
The “silent killer” causes cardiovascular disease, kidney disease, blindness, and in some cases requires amputations of body limbs.